Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Mann

Showing results (881-890 of 909) with videos related to

Pageof 91
Sort By:
JAMA|November 7, 2018
Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: The INDIE-HFpEF Randomized Clinical TrialBarry A Borlaug, Kevin J Anstrom, Gregory D Lewis, et al.
Journal of the American College of Cardiology|May 20, 2026
Vagal Nerve Stimulation in Patients With Heart Failure and Reduced Ejection Fraction: The ANTHEM-HFrEF TrialMarvin A Konstam, James E Udelson, Douglas L Mann, et al.
Circulation|November 2, 2022
The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI TrialRoxana Mehran, Philippe Gabriel Steg, Marc A Pfeffer, et al.
Circulation. Heart Failure|May 19, 2020
Comorbid Conditions and Health-Related Quality of Life in Ambulatory Heart Failure Patients: REVIVAL (Registry Evaluation of Vital Information for VADs in Ambulatory Life REVIVAL)Thomas M Cascino, Michelle M Kittleson, Anuradha Lala, et al.
Circulation. Heart Failure|February 1, 2024
Proteomic Associations of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) in Heart Failure With Preserved Ejection FractionJoe David Azzo, Marie-Joe Dib, Loukas Zagkos, et al.
The American Journal of Cardiology|July 25, 2018
Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial)Tetz C Lee, Min Qian, Gregory Y H Lip, et al.
ESC Heart Failure|March 1, 2019
Association between mortality and implantable cardioverter-defibrillators by aetiology of heart failure: a propensity-matched analysis of the WARCEF trialTetz C Lee, Min Qian, Lan Mu, et al.
JACC. Heart Failure|November 30, 2019
Cognitive Decline Over Time in Patients With Systolic Heart Failure: Insights From WARCEFTetz C Lee, Min Qian, Yutong Liu, et al.
Journal of Cardiac Failure|December 7, 2019
Impact of Socioeconomic Factors on Patient Desire for Early LVAD Therapy Prior to Inotrope DependenceInna Tchoukina, Keyur B Shah, Jennifer T Thibodeau, et al.
Journal of the American Heart Association|August 29, 2024
Proteomic Correlates and Prognostic Significance of Kidney Injury in Heart Failure With Preserved Ejection FractionOday Salman, Lei Zhao, Jordana B Cohen, et al.
Pageof 91

Showing results (881-890 of 909) with videos related to

Sort By:
Pageof 91
JAMA|November 7, 2018
Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: The INDIE-HFpEF Randomized Clinical TrialBarry A Borlaug, Kevin J Anstrom, Gregory D Lewis, et al.
Journal of the American College of Cardiology|May 20, 2026
Vagal Nerve Stimulation in Patients With Heart Failure and Reduced Ejection Fraction: The ANTHEM-HFrEF TrialMarvin A Konstam, James E Udelson, Douglas L Mann, et al.
Circulation|November 2, 2022
The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI TrialRoxana Mehran, Philippe Gabriel Steg, Marc A Pfeffer, et al.
Circulation. Heart Failure|May 19, 2020
Comorbid Conditions and Health-Related Quality of Life in Ambulatory Heart Failure Patients: REVIVAL (Registry Evaluation of Vital Information for VADs in Ambulatory Life REVIVAL)Thomas M Cascino, Michelle M Kittleson, Anuradha Lala, et al.
Circulation. Heart Failure|February 1, 2024
Proteomic Associations of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) in Heart Failure With Preserved Ejection FractionJoe David Azzo, Marie-Joe Dib, Loukas Zagkos, et al.
The American Journal of Cardiology|July 25, 2018
Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial)Tetz C Lee, Min Qian, Gregory Y H Lip, et al.
ESC Heart Failure|March 1, 2019
Association between mortality and implantable cardioverter-defibrillators by aetiology of heart failure: a propensity-matched analysis of the WARCEF trialTetz C Lee, Min Qian, Lan Mu, et al.
JACC. Heart Failure|November 30, 2019
Cognitive Decline Over Time in Patients With Systolic Heart Failure: Insights From WARCEFTetz C Lee, Min Qian, Yutong Liu, et al.
Journal of Cardiac Failure|December 7, 2019
Impact of Socioeconomic Factors on Patient Desire for Early LVAD Therapy Prior to Inotrope DependenceInna Tchoukina, Keyur B Shah, Jennifer T Thibodeau, et al.
Journal of the American Heart Association|August 29, 2024
Proteomic Correlates and Prognostic Significance of Kidney Injury in Heart Failure With Preserved Ejection FractionOday Salman, Lei Zhao, Jordana B Cohen, et al.
Pageof 91